Advisors Asset Management, Inc. Regenxbio Inc. Transaction History

Advisors Asset Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$19.35 - $35.04 $75,213 - $136,200	-3,887 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$24.62 - $34.31 $19,572 - $27,276	-795 Reduced 16.98%	3,887 $129,000
Q4 2021 Feb 15, 2022	SELL	$30.19 - $40.28 $1,358 - $1,812	-45 Reduced 0.95%	4,682 $153,000
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $87 - $137	-3 Reduced 0.06%	4,727 $198,000
Q2 2021 Jul 30, 2021	SELL	$32.46 - $40.48 $584 - $728	-18 Reduced 0.38%	4,730 $184,000
Q1 2021 May 07, 2021	SELL	$33.61 - $49.95 $4,033 - $5,994	-120 Reduced 2.47%	4,748 $162,000
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $9,467 - $17,617	357 Added 7.91%	4,868 $221,000
Q3 2020 Nov 16, 2020	BUY	$27.01 - $40.26 $56,450 - $84,143	2,090 Added 86.33%	4,511 $124,000
Q2 2020 Aug 12, 2020	BUY	$27.75 - $43.44 $67,182 - $105,168	2,421 New	2,421 $89,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $369M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.